White Paper
Value-Based Market Access Symposium Summary Report
Feb 09, 2023
Download

On 27 June 2022, APACMed held the inaugural Value-Based Market Access Symposium. The Symposium leveraged on technical expertise and real-world operating experience from government affairs and market access industry professionals across 15 APAC markets and 40 companies operating in the medical devices and diagnostics sector. IQVIA being a knowledge partner, developed the report which summarizes the insights shared to facilitate innovative, value-based market access, including in pricing, procurement, and reimbursement.

The Value-Based Health Care system (VBHC) is a framework for restructuring health care systems with the overarching goal of maximizing value for patients, where value is defined as health outcomes per unit of cost. The VBHC system can not only lower health care costs with better outcomes in patients, but also make health care by providers more efficient and targeted, thereby enhancing patient satisfaction. With VBHC systems in place, payers will have evidence based metrics for cost control and risk reduction, while industries will be able to align their prices catered more towards patient outcomes. All these factors will in turn benefit society with subsequent reduction in health care spending and prospects of a better overall health scenario. MedTech can significantly contribute across the care continuum that spans prevention, screening, treatment, recovery, and sustainability. Areas of contribution involve device innovation, data analytics, telehealth solutions, and partnership with providers, health assessment technology bodies and payers. The central theme, however, remains universal evidence-based improvement in patient outcomes.

Contact Us